Gerry Davies MD, is Senior Lecturer and Honorary Consultant in Infectious Diseases at the University of Liverpool. He ran the TB programme at Hlabisa hospital, Kwazulu/Natal, South Africa from 1994-1998, later obtaining an Msc in Epidemiology from the London School of Hygiene and a PhD in Pharmacology from the University of Liverpool. In 2009, he completed a Wellcome Trust Training Fellowship based at the Mahidol-Oxford Research Unit in Bangkok where he worked on clinical studies of anti-tuberculosis and influenza therapy. He is currently managing PKPDia, an international collaboration aiming to advance pharmacokinetic-pharmacodynamic analysis in TB,HIV and Malaria and is tuberculosis editor for the Cochrane Infectious Diseases Group. Current Research Interests : Pharmacokinetics, pharmacodynamics and mathematical modelling of anti-tuberculosis therapy, bacteriological and other biomarkers of treatment response, clinical trial.